» Articles » PMID: 29234087

Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B

Overview
Journal Sci Rep
Specialty Science
Date 2017 Dec 14
PMID 29234087
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The APOBEC3B (A3B) single-stranded DNA (ssDNA) cytosine deaminase has important roles in innate immunity but is also a major endogenous source of mutations in cancer. Previous structural studies showed that the C-terminal catalytic domain of human A3B has a tightly closed active site, and rearrangement of the surrounding loops is required for binding to substrate ssDNA. Here we report structures of the A3B catalytic domain in a new crystal form that show alternative, yet still closed, conformations of active site loops. All-atom molecular dynamics simulations support the dynamic behavior of active site loops and recapitulate the distinct modes of interactions that maintain a closed active site. Replacing segments of A3B loop 1 to mimic the more potent cytoplasmic deaminase APOBEC3A leads to elevated ssDNA deaminase activity, likely by facilitating opening of the active site. These data collectively suggest that conformational equilibrium of the A3B active site loops, skewed toward being closed, controls enzymatic activity by regulating binding to ssDNA substrates.

Citing Articles

Regulatory interactions between APOBEC3B N- and C-terminal domains.

Braza M, Demir O, Ahn S, Morris C, Calvo-Tusell C, McGuire K bioRxiv. 2024; .

PMID: 39713448 PMC: 11661193. DOI: 10.1101/2024.12.11.628032.


ATR safeguards replication forks against APOBEC3B-induced toxic PARP1 trapping.

Ortega P, Bournique E, Li J, Sanchez A, Santiago G, Harris B bioRxiv. 2024; .

PMID: 39605722 PMC: 11601322. DOI: 10.1101/2024.11.14.623607.


Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes.

Sanchez A, Ortega P, Sakhtemani R, Manjunath L, Oh S, Bournique E Nat Commun. 2024; 15(1):2370.

PMID: 38499542 PMC: 10948877. DOI: 10.1038/s41467-024-45909-5.


APOBEC3A Catalytic Inactivity Mutation Induces Tertiary Structure Destabilization.

Jones K, Shehata M, Carpenter M, Amaro R, Harki D ACS Med Chem Lett. 2023; 14(3):338-343.

PMID: 36923917 PMC: 10009786. DOI: 10.1021/acsmedchemlett.2c00517.


Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.

Roelofs P, Martens J, Harris R, Span P Clin Cancer Res. 2022; 29(9):1658-1669.

PMID: 36478188 PMC: 10159886. DOI: 10.1158/1078-0432.CCR-22-2861.


References
1.
Thielen B, McNevin J, McElrath M, Vander Stoep Hunt B, Klein K, Lingappa J . Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms. J Biol Chem. 2010; 285(36):27753-66. PMC: 2934643. DOI: 10.1074/jbc.M110.102822. View

2.
Walker B, Wardell C, Murison A, Boyle E, Begum D, Dahir N . APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun. 2015; 6:6997. PMC: 4568299. DOI: 10.1038/ncomms7997. View

3.
Rostkowski M, Olsson M, Sondergaard C, Jensen J . Graphical analysis of pH-dependent properties of proteins predicted using PROPKA. BMC Struct Biol. 2011; 11:6. PMC: 3038139. DOI: 10.1186/1472-6807-11-6. View

4.
Harris R, Dudley J . APOBECs and virus restriction. Virology. 2015; 479-480:131-45. PMC: 4424171. DOI: 10.1016/j.virol.2015.03.012. View

5.
Emsley P, Lohkamp B, Scott W, Cowtan K . Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 4):486-501. PMC: 2852313. DOI: 10.1107/S0907444910007493. View